Literature DB >> 34474480

Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children.

Laura Avila1,2, Nour Amiri1,2, Riddhita De1,2, Jennifer Vincelli1, Eleanor Pullenayegum1,2, Suzan Williams1, Leonardo R Brandão1,2.   

Abstract

Our understanding of postthrombotic syndrome (PTS) predictors in children is evolving. The present study aimed to investigate differences in patient- and deep vein thrombosis (DVT)-related characteristics between central venous catheter (CVC)-related and non-CVC-related thrombosis in children, as well as early PTS predictors. Children aged 0 to 18 years were prospectively recruited ≥6 months after imaging-proven upper- or lower-extremity DVT. PTS was measured using CAPTSure. Early predictors included age at DVT diagnosis, DVT symptoms, DVT burden, and days on therapeutic anticoagulation within 30 days post-DVT diagnosis. Analysis of predictors was stratified by CVC-related and non-CVC-related thrombosis. Generalized estimating equations were used for data analyses. In total, 313 DVT-affected extremities of 256 patients were assessed; 275 (88%) DVT cases were CVC related. Patients with non-CVC-related thrombosis were older (median age, 5.8 years; 25th-75th percentile, 4.9-6.4 years vs 3.5 months; 25th-75th percentile, 0.7-18.7 months; P < .001) and more likely to have thrombophilia (64% vs 22%; P < .001) and obesity (30% vs 13%; P = .01) than patients with CVC-related thrombosis. CAPTSure scores were 9.5 points higher (standard error, 3.0; P = .02) in the non-CVC-related thrombosis stratum. Age at the time of DVT predicted PTS in both strata; DVT burden and time from DVT diagnosis to PTS assessment predicted PTS in CVC-related thrombosis. In sum, PTS severity was higher in non-CVC-related vs CVC-related thrombosis. Increasing age at the time of DVT was associated with higher PTS severity. DVT burden and time from DVT diagnosis to PTS assessment were significant PTS predictors in CVC-related thrombosis, indicating that long-term follow-up of these children is important.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34474480      PMCID: PMC8679675          DOI: 10.1182/bloodadvances.2021004727

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  66 in total

1.  Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency.

Authors:  J P Galanaud; C A Holcroft; M A Rodger; M J Kovacs; M T Betancourt; P S Wells; D R Anderson; I Chagnon; G Le Gal; S Solymoss; M A Crowther; A Perrier; R H White; L M Vickars; T Ramsay; S R Kahn
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824

2.  Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis.

Authors:  S R Kahn; C Kearon; J A Julian; B Mackinnon; M J Kovacs; P Wells; M A Crowther; D R Anderson; P Van Nguyen; C Demers; S Solymoss; J Kassis; W Geerts; M Rodger; J Hambleton; J S Ginsberg
Journal:  J Thromb Haemost       Date:  2005-02-23       Impact factor: 5.824

3.  Prevalence and risk factors for post thrombotic syndrome after deep vein thrombosis in children: a cohort study.

Authors:  Riten Kumar; Vilmarie Rodriguez; Jane M S Matsumoto; Shakila P Khan; Amy L Weaver; Robert D McBane; Timothy J Beebe; John A Heit
Journal:  Thromb Res       Date:  2014-12-05       Impact factor: 3.944

4.  Hypercoagulable states in primary upper-extremity deep vein thrombosis.

Authors:  E Héron; O Lozinguez; M Alhenc-Gelas; J Emmerich; J N Fiessinger
Journal:  Arch Intern Med       Date:  2000-02-14

5.  Chronic Complications After Femoral Central Venous Catheter-related Thrombosis in Critically Ill Children.

Authors:  Jeanine J Sol; Hennie Knoester; Marjorie de Neef; Anne M J B Smets; Aukje Betlem; C Heleen van Ommen
Journal:  J Pediatr Hematol Oncol       Date:  2015-08       Impact factor: 1.289

6.  Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study.

Authors:  E M Roumen-Klappe; M C H Janssen; J Van Rossum; S Holewijn; M M J A Van Bokhoven; K Kaasjager; H Wollersheim; M Den Heijer
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

7.  Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.

Authors:  R S Chitsike; M A Rodger; M J Kovacs; M T Betancourt; P S Wells; D R Anderson; I Chagnon; G LE Gal; S Solymoss; M A Crowther; A Perrier; R H White; L M Vickars; T Ramsay; S R Kahn
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

8.  Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis.

Authors:  L W Tick; M H H Kramer; F R Rosendaal; W R Faber; C J M Doggen
Journal:  J Thromb Haemost       Date:  2008-10-04       Impact factor: 5.824

9.  Levels of inflammatory markers and the development of the post-thrombotic syndrome.

Authors:  Hadia Shbaklo; Christina A Holcroft; Susan R Kahn
Journal:  Thromb Haemost       Date:  2009-03       Impact factor: 5.249

10.  Acute prognostic factors for post-thrombotic syndrome in children with limb DVT: a bi-institutional cohort study.

Authors:  Courtney A Lyle; Elizabeth Gibson; Amy E Lovejoy; Neil A Goldenberg
Journal:  Thromb Res       Date:  2012-11-26       Impact factor: 3.944

View more
  2 in total

1.  Study on the Effect and Mechanism of miR-185 on Lower Extremity Deep Venous Thrombosis.

Authors:  Ran Lu; Wei Zhu; Haobo Sun; Liang Zhang; Zhaowen Yu; Zhonglin Nie; Yong Gao
Journal:  Mol Biotechnol       Date:  2021-10-14       Impact factor: 2.695

2.  Impact of deep vein thrombosis on adolescent athletes: Navigating an invisible disability.

Authors:  Denise Bastas; Jennifer Vincelli; Riddhita De; Eliana Benia; Sarah Gairdner; Leonardo R Brandão; Laura Avila
Journal:  Res Pract Thromb Haemost       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.